- Home
- CFR vs LNTH Comparison
CFR vs LNTH Comparison
Compare CFR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFR | LNTH |
|---|---|---|
| Founded | 1868 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 4.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | CFR | LNTH |
|---|---|---|
| Price | $128.80 | $66.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 6 |
| Target Price | ★ $138.33 | $77.33 |
| AVG Volume (30 Days) | 441.1K | ★ 1.0M |
| Earning Date | 01-29-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ 20.47 | N/A |
| EPS | ★ 9.72 | 2.39 |
| Revenue | ★ $2,141,575,000.00 | $1,525,933,000.00 |
| Revenue This Year | $14.17 | $0.01 |
| Revenue Next Year | $4.47 | $1.24 |
| P/E Ratio | ★ $13.29 | $27.84 |
| Revenue Growth | ★ 9.02 | 1.95 |
| 52 Week Low | $100.31 | $47.25 |
| 52 Week High | $146.44 | $111.29 |
Technical Indicators
Market Signals| Indicator | CFR | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 60.18 | 72.55 |
| Support Level | $125.01 | $60.15 |
| Resistance Level | $131.54 | $64.40 |
| Average True Range (ATR) | 2.35 | 2.09 |
| MACD | 0.67 | 0.66 |
| Stochastic Oscillator | 74.32 | 94.44 |
Price Performance
Historical ComparisonAbout CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $50 billion in assets (as of mid-2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.